Previous studies have shown that the TNF‐α levels in the peripheral blood of AD group were higher than in that of healthy control group (Swardfager et al., 2010), and that elevated levels of TNF‐α from the periphery, which are linked to systemic inflammation, are associated with cognitive decline in AD patients (Kim et al., 2017). Here, TNF is linked to Alzheimer disease.